Jiufuyuan Biotechnology Company Limited (JFY)

JFY Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	0.74	0.74	0.64
Cash & Cash Equivalents	0.74	0.74	0.64
Cash Growth	-	16.51%	-
Receivables	0.49	0.49	0.34
Inventory	1.28	1.28	1.37
Other Current Assets	0.81	0.81	0.46
Total Current Assets	3.32	3.32	2.8
Property, Plant & Equipment	3.37	3.37	3.73
Total Long-Term Assets	3.37	3.37	3.73
Total Assets	6.69	6.69	6.53
Accounts Payable	0.23	0.23	0.29
Current Debt	2.17	2.17	2.36
Other Current Liabilities	0.18	0.18	0.26
Total Current Liabilities	2.59	2.59	2.91
Total Liabilities	2.59	2.59	2.91
Total Debt	2.17	2.17	2.36
Debt Growth	-	-7.77%	-
Retained Earnings	1.1	1.1	0.43
Comprehensive Income	-0.08	-0.08	0.12
Shareholders' Equity	4.1	4.1	3.63
Net Cash / Debt	-1.43	-1.43	-1.72
Working Capital	0.73	0.73	-0.1

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).